PHILADELPHIA – Researchers from the University of Pennsylvania School of Medicine will be presenting at the annual meeting of the International Society for Stem Cell Research (ISCCR) as well as participating in a Workshop and an Evening Public Symposium on Stem Cell Biology.

The 6th annual meeting of the ISSCR will be held from June 11-14, 2008 in Philadelphia, PA. The Penn Institute for Regenerative Medicine, the School of Medicine Department of Cell and Developmental Biology, and the ISSCR are hosting the free Workshop and Evening Public Symposium on June 10, just prior to the scientific meeting.

Highlights of Penn scientific presentations:

  • Mayumi Ito
    Department of Dermatology

    The role of the Wnt protein in hair follicle differentiation after wounding or UV-B irradiation
  • M. Celeste Simon
    HHMI, Abramson Family Cancer Research Institute

    The interplay of oxygen availability, embryonic development, and stem cell function
  • Eric J. Brown
    Abramson Family Cancer Research Institute

    The interplay between premature aging, tissue regeneration, and the tumor suppressor p53
  • Monica Teta
    Department of Dermatology
    The role of micro RNAs in hair follicle stem cells

Workshop in Stem Cell Biology: June 10
Marriott Philadelphia Downtown
Main Tower: Grand Ballroom
Salon E, 5th Floor

  • Delve into the latest advances and fundamental basics of stem cell biology and regenerative medicine
  • Learn to apply the language and basics of stem cell science in the classroom
  • Gain expert insights into the political and ethical issues surrounding stem cell science
  • Hear from the leading voices in stem cell research

1:00-1:05

Welcome

Jonathan A. Epstein, MD
Co-Director, Institute for Regenerative Medicine,
University of Pennsylvania

1:05-1:30

Introduction to
Stem Cell Biology I

Douglas A. Melton, PhD
Co-Director, Harvard Stem Cell Institute

1:30-1:55

Introduction to
Stem Cell Biology II

Nadia Rosenthal, PhD
Head, Monterotondo Outstation
European Molecular Biology Laboratory

1:55-2:20

Stem Cells for
Neurological Disorders

John Gearhart, PhD
Director, Institute for Cell Engineering,
Johns Hopkins University School of Medicine

2:20-2:45

Stem Cells for Heart Disease

Jonathan Epstein, MD
Co-Director, Institute for Regenerative Medicine, 
University of Pennsylvania

2:45-3:00

Break

 

3:00-3:25

Cancer Stem Cells

M. Celeste Simon, PhD
Howard Hughes Medical Institute and University of Pennsylvania School of Medicine

3:25-3:50

Stem Cells of the Blood
and Bone Marrow

Stephen G. Emerson, MD, PhD
President,  Haverford College

3:50-4:15

Many Ways to Generate
Stem Cells

George Q. Daley, MD, PhD
ISSCR President
Children’s Hospital Boston and Harvard Medical School

4:15-4:40

Legal and Ethical Considerations

Jonathan D. Moreno, PhD
Professor, Medical Ethics and History and Sociology of Science
University of Pennsylvania

4:40-5:00

Wrap-up and Questions

 

Evening Public Symposium
June 10, 2008
6:00 p.m. – 7:30 p.m. 
Marriott Philadelphia Downtown
Main Tower: Grand Ballroom
Salons A-F, 5th Floor

The Evening Public Symposium is for anyone interested in stem cells, public policy and biomedical research. Scientific and advocacy leaders will comment on the ethical debates and concerns associated with the latest stem cell research.  The evening will feature the following panelists:

John Gearhart, PhD, Director, Institute for Cell Engineering, Johns Hopkins University School of Medicine
Stephen G. Emerson, MD, PhD, President, Haverford College
Jonathan D. Moreno, PhD, Professor, Medical Ethics and History and Sociology of Science, University of Pennsylvania
Marie McCullough, Medical Reporter, The Philadelphia Inquirer
Amy Comstock Rick, President, Coalition for the Advancement of Medical Research, CEO, Parkinson’s Action Network

Editors Note:
For scientific presentations: Contact Karen Kreeger for more information.

Public events on June 10: Open to anyone interested in stem cells, public policy, and biomedical research. Space is limited for the workshop. Priority will be given to attendees who have pre-registered. For more information and to register for these events, please visit: http://www.isscr.org/meetings/pub_symp.htm

###

PENN Medicine is a $3.5 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is currently ranked #4 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals — its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation’s “Honor Roll” hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center — a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.

The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.

The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.

Share This Page: